# Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions

> **NCT00653458** · PHASE1 · COMPLETED · sponsor: **Par Pharmaceutical, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ondansetron
- **DRUG:** Zofran

## Key facts

- **NCT ID:** NCT00653458
- **Lead sponsor:** Par Pharmaceutical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2002-09
- **Final completion:** 2002-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2008-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00653458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00653458, "Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00653458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*